Addback of Donor CD45RA Depleted Cells
CD45RA Depleted Peripheral Stem Cell Addback for Patients at Risk for Viral or Fungal Infections Post TCRαβ/CD19 Depleted Hematopoietic Stem Cell Transplant
More Information
- Trial Status
- Accepting patients
- Enrollment
- 50 patients (estimated)
- Sponsors
- Children's Hospital of Philadelphia
- Tags
- Allogeneic Stem Cell Transplant, Chemotherapy, Donor Lymphocyte Infusion (DLI), T Cell, Radiation Therapy
- Trial Type
- Supportive
- Last Update
- 1 month ago
- SparkCures ID
- 1653
- NCT Identifier
- NCT03810196
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.